Yarema Kristin
Transaction: 07/25/2026
SELL
Change
-115,129
Price
Not reported
Filing
07/28/2026
Type
SELL
ImageneBio Inc
IMA • Biotechnology
$4.85
▼ -0.04 (-0.72%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$78.38M
Growth
29.0%
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.08Healthy liquidity · 12.49Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 1:44 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$4.85
Change-0.72%
Shares Out16.16M
Market Cap$78.38M
Enterprise Value$-57.77M
52W Range3.94 - 15.79
Beta0.76
P/E-1.49
P/B0.55
P/FCF-1.36
EV/EBITDA1.06
EV/FCF1.00
Price$4.85
Change-0.72%
Shares Out16.16M
Market Cap$78.38M
Enterprise Value$-57.77M
52W Range3.94 - 15.79
Beta0.76
P/E-1.49
P/B0.55
P/FCF-1.36
EV/EBITDA1.06
EV/FCF1.00
Earnings Yield-66.96%
FCF Yield-73.65%
Dividend Yield0.00%
Gross Margin-29.13%
Oper. Margin-60.56%
Profit Margin-56.69%
Debt/Eq0.08
Current Ratio12.49
Quick Ratio12.49
Revenue 5Y29.01%
Target$1.33
Target Upside-72.58%
Target Median$1.33
Target Range1.33 - 1.33
Volume0.00
Avg Volume21.17K
EPS Surprise-0.25
Investment DNA
How strong this company looks for long-term investors
36
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
58/100
Why this score▼
Manageable debt level · 0.08Healthy liquidity · 12.49Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 5 analyst votes · 2026-09-05
80/100
Bullish
Bullish
4
Hold
0
Bearish
1
Price Target
2026-08-07
Low
$1.33
Mean
$1.33
Median
$1.33
High
$1.33
Insider Transactions
Recent executive and insider activity
⚠ 1 high-volume insider sell detected
Yarema Kristin
Transaction: 07/25/2026
BUY
Change
+38,376
Price
Not reported
Filing
07/28/2026
Type
BUY
Grant-Huerta Yanina
Transaction: 07/20/2026
OTHER
Change
0
Price
Not reported
Filing
07/28/2026
Type
OTHER
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Yarema Kristin | SELL | -115,129 | Not reported | 07/25/2026 | 07/28/2026 |
| Yarema Kristin | BUY | +38,376 | Not reported | 07/25/2026 | 07/28/2026 |
| Grant-Huerta Yanina | OTHER | 0 | Not reported | 07/20/2026 | 07/28/2026 |
| Lally Robert B | SELL | -1,525 | $5.34 | 07/17/2026 | 07/20/2026 |
| Lally Robert B | SELL | -1,671 | $5.50 | 07/16/2026 | 07/20/2026 |
| Bonita David P | BUY | +15,600 | $5.45 | 06/16/2026 | 06/18/2026 |
| SLATTERY JOSEPH P | BUY | +15,600 | $5.45 | 06/16/2026 | 06/18/2026 |
| Stampacchia Otello | BUY | +15,600 | $5.45 | 06/16/2026 | 06/18/2026 |
| Wang Jonathan Jian | BUY | +15,600 | $5.45 | 06/16/2026 | 06/18/2026 |
| Lally Robert B | OTHER | +25,410 | $6.20 | 03/20/2026 | 04/20/2026 |
| Lally Robert B | OTHER | 0 | Not reported | 03/20/2026 | 04/20/2026 |
| Su Wei-guo | OTHER | 0 | Not reported | 04/16/2026 | 04/16/2026 |
| ORBIMED ADVISORS LLC | BUY | +336,603 | $0.00 | 04/14/2026 | 04/16/2026 |
| Bonita David P | BUY | +336,603 | $0.00 | 04/14/2026 | 04/16/2026 |
| Yarema Kristin | BUY | +85,400 | Not reported | 03/16/2026 | 03/18/2026 |
| Yarema Kristin | BUY | +128,100 | $6.20 | 03/16/2026 | 03/18/2026 |
| Porter-Brown Benjamin | OTHER | 0 | Not reported | 02/16/2026 | 02/20/2026 |
| Butler Erin | BUY | +22,500 | $7.11 | 12/30/2025 | 01/02/2026 |
| Butler Erin | BUY | +22,500 | Not reported | 12/30/2025 | 01/02/2026 |
| SLATTERY JOSEPH P | BUY | +16,000 | $5.99 | 12/24/2025 | 12/29/2025 |